ZOLGENSMA (Onasemnogene abeparvovec-xioi) for injection is used for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA).

ZOLGENSMA (onasemnogene abeparvovec-xioi) is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.
Limitation of Use:
• The safety and effectiveness of repeat administration of ZOLGENSMA have not been evaluated.
• The use of ZOLGENSMA in patients with advanced SMA (e.g., complete paralysis of limbs, permanent ventilator dependence) has not been evaluated.

ZOLGENSMA (onasemnogene abeparvovec-xioi) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ZOLGENSMA (onasemnogene abeparvovec-xioi) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ZOLGENSMA (onasemnogene abeparvovec-xioi) medicine cost price in India.

The order for ZOLGENSMA (onasemnogene abeparvovec-xioi) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Onasemnogene abeparvovec, sold under the brand name Zolgensma, is a gene therapy medication used to treat spinal muscular atrophy (SMA). It was approved for children less than two years old in 2019. It is used as a one-time injection into a vein with at least two months of corticosteroids. Onasemnogene abeparvovec was approved for medical use in the United States in 2019, and in Japan and the European Union in 2020.

ZOLGENSMA (onasemnogene abeparvovec-xioi) Suspension for intravenous infusion Initial U.S. Approval: 2019

Generic Name: Onasemnogene abeparvovec-xioi

ZOLGENSMA is a suspension for intravenous infusion, supplied as single-use vials.
ZOLGENSMA is provided in a kit containing 2 to 9 vials, as a combination of 2 vial fill volumes (either 5.5 mL or 8.3 mL). All vials have a nominal concentration of 2.0 × 1013 vector genomes (vg) per mL.
Each vial of ZOLGENSMA contains an extractable volume of not less than either 5.5 mL or 8.3 mL. vial

ZOLGENSMA (onasemnogene abeparvovec-xioi)

with Indian Pharma Network

IPN, Delhi can help you access to ZOLGENSMA (Onasemnogene abeparvovec-xioi) in India.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support


ZOLGENSMA (onasemnogene abeparvovec-xioi)

Dosage Forms and Strengths ReadMore

SMA drug Zolgensma® has “significant therapeutic benefit”, according to interim data ReadMore

Novartis Gene Therapies president talks Zolgensma competition, path forward for new formulation ReadMore

ZOLGENSMA (Onasemnogene abeparvovec-xioi) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ZOLGENSMA (Onasemnogene abeparvovec-xioi) on prescription and Import License in Patient's Name only.

For overseas patients, ZOLGENSMA (Onasemnogene abeparvovec-xioi) can be made available in Send your enquiry to find ZOLGENSMA (Onasemnogene abeparvovec-xioi) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Four steps to access the medicines you need

How and where to buy ZOLGENSMA (Onasemnogene abeparvovec-xioi):
You can order ZOLGENSMA from Indian Pharma Network if the drug has not been approved or is not available in your country.

Step 1
You send a request for your medicine online Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2
We verify your prescription and medical details
Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3
We source your medicine
Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4
We deliver your medicine
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number :07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 6,000 patients.

Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.

Get Access To FDA Approved Drug ZOLGENSMA (onasemnogene abeparvovec-xioi) suspension In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in spinal muscular atrophy treatment. Brand Name "ZOLGENSMA (onasemnogene abeparvovec-xioi) suspension" or Generic Name "onasemnogene abeparvovec-xioi suspension" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.